Indicators on euthanasia sodium pentobarbital You Should Know
Indicators on euthanasia sodium pentobarbital You Should Know
Blog Article
Contraindicated (one)pentobarbital will decrease the level or influence of cariprazine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. CYP3A4 is liable for the development and elimination of cariprazine's active metabolites.
pentobarbital raises effects of ifosfamide by influencing hepatic enzyme CYP2B6 metabolism. Use Warning/Keep an eye on. Coadministration of ifosfamide with CYP2B6 inducers may possibly increase metabolism of ifosfamide to its metabolite. Watch for enhanced effects/toxicities if combined with CYP2B6 inducers.
pentobarbital will lower the level or influence of tacrolimus by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
pentobarbital will lessen the extent or effect of nateglinide by influencing hepatic enzyme CYP2C9/10 metabolism. Use Caution/Watch.
pentobarbital will lessen the level or impact of copyright topical by affecting hepatic enzyme CYP2B6 metabolism. Minimal/Importance Mysterious.
pentobarbital will minimize the level or effect of darunavir by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
With therapeutic doses of TCAs, barbiturates enhance metabolism and reduce blood concentrations of TCAs.
pentobarbital will minimize the level or effect of nelfinavir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital will lower the level or impact of sunitinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check.
pentobarbital will decrease the level or impact of doravirine by affecting hepatic/intestinal enzyme CYP3A4 metabolism.
pentobarbital decreases amounts of elvitegravir/cobicistat/emtricitabine/tenofovir DF by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. May possibly produce lack of virologic reaction and probable resistance.
pentobarbital will decrease the level or influence of tramadol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on. Lessened AUC of tramadol along with the Energetic metabolite (O-desmethyltramadol) when coadministered with solid CYP3A4 and CYP2B6 inducers
Contraindicated (1)pentobarbital will lower the level or effect of lonafarnib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Lonafarnib can be a sensitive CYP3A4 substrate. Coadministration with check here robust or moderate CYP3A4 inducers is contraindicated.
pentobarbital will lessen the level or influence of isavuconazonium sulfate by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.